Tofersen helps people with ALS caused by an SOD1 mutation
Channel: Randompile
Date: 2022-11-15

SYNOPSIS:
 ▸ Amyotrophic lateral sclerosis, or ALS, is a devastating motor neuron disease affecting muscle function. 
 ▸ In 2022, the results of a phase-three clinical trial of the drug tofersen for people with SOD1 ALS were published.

MORE INFO:
 ▸ https://bit.ly/yt-tofersen

Produced by:
 ▸ https://randompile.net/

#als #tofersen #biology #biomedicine #genetherapy